Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818140 | PMC |
| http://dx.doi.org/10.1503/cmaj.1150096 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Management of opioid use disorder: 2024 update to the national clinical practice guideline.
CMAJ
November 2024
Department of Psychology and Neuroscience (Yakovenko, Belliveau, Fraleigh, Stewart); Department of Psychiatry (Yakovenko, Stewart), Dalhousie University, Halifax, NS; Research Centre of Centre Hospitalier de l'Université de Montréal (Mukaneza, Germé), Montréal, Que.; Department of Medicine (Bach, Wood), University of British Columbia; British Columbia Centre on Substance Use (Bach, Wood), Vancouver, BC; Waypoint Centre for Mental Health Care (Poulin); Department of Psychiatry (Poulin), University of Manitoba, Winnipeg, Man.; Addictions Divisions (Selby), Centre for Addition and Mental Health; Dalla Lana School of Public Health (Selby, Rehm), University of Toronto, Toronto, Ont.; Department of Family Medicine and Emergency Medicine (Goyer, Bruneau), Université de Montréal; Centre de recherche et d'aide pour narcomanes (Goyer), Centre intégré universitaire de santé et de services sociaux du Centre-Sud-del'Île-de Montréal, Montréal, Que.; Division of General Internal Medicine (Brothers), Department of Medicine, Dalhousie University, Halifax, NS; Addiction Medicine Consult Service, Mental Health & Addictions Program (Brothers), Nova Scotia Health; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (Rehm), Toronto, Ont.; Department of Psychology (Hodgins), University of Calgary; Department of Psychology (Hodgins), Alberta Gambling Research Institute, Calgary, Alta.; Drug addiction service (Bruneau), Centre Hospitalier de l'Université de Montréal, Montréal, Que.
Article Synopsis
- - The 2024 update of the 2018 National Guideline for Clinical Management of Opioid Use Disorder emphasizes the need for current scientific evidence to inform treatment practices for opioid use disorder in Canada.
- - A comprehensive review from 2017 to 2023 was conducted to revise the guidelines, involving a national committee including those with personal experience in opioid use disorder, and ensuring quality through established methods.
- - Key changes in the recommendations include recognizing methadone and buprenorphine as equally effective first-line treatments, introducing slow-release oral morphine as a second-line option, and highlighting that psychosocial interventions should be optional rather than mandatory.
Temporal trends and practice variation of paediatric diagnostic tests in primary care: retrospective analysis of 14 million tests.
Fam Med Community Health
October 2024
Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Objective: The primary objective was to investigate temporal trends and between-practice variability of paediatric test use in primary care.
Methods And Analysis: This was a descriptive study of population-based data from Clinical Practice Research Datalink Aurum primary care consultation records from 1 January 2007 to 31 December 2019. Children aged 0-15 who were registered to one of the eligible 1464 general practices and had a diagnostic test code in their clinical record were included.
Public funding for private for-profit centres and access to cataract surgery by patient socioeconomic status: an Ontario population-based study.
CMAJ
August 2024
ICES (Campbell, Bell, Urbach, Paterson, Stukel, Gill, Baxter, Wilton, Gomez), Toronto, Ont.; Department of Ophthalmology (Campbell), Queen's University; Department of Ophthalmology (Campbell), Kingston Health Sciences Centre, Hotel Dieu Hospital site, Kingston, Ont.; Department of Ophthalmology (El-Defrawy), University of Toronto; Department of Ophthalmology (El-Defrawy), Kensington Eye Institute; Department of Medicine (Bell), University of Toronto; Institute of Health Policy, Management and Evaluation (Bell, Paterson, Stukel), University of Toronto; Department of Medicine (Bell), Sinai Health System; Department of Surgery (Urbach, Baxter, Gomez), Temerty Faculty of Medicine, University of Toronto, Toronto, Ont.; Department of Family Medicine, McMaster University, Hamilton, Ont.; Division of Geriatric Medicine (Gill), Queen's University; Division of Geriatric Medicine (Gill), Providence Care Hospital, Kingston, Ont.; Departments of Otolaryngology, Head and Neck Surgery and Surgical Oncology (Irish), University Health Network; Cancer Care Ontario (Irish); Li Ka Shing Knowledge Institute (Baxter, Gomez), St. Michael's Hospital, Toronto, Ont.; Melbourne School of Population and Global Health (Baxter), University of Melbourne, Melbourne, AU; Unity Health Toronto (Gomez), St. Michael's Hospital, Toronto, Ont.
Background: Public funding of cataract surgery provided in private, for-profit surgical centres increased to help mitigate surgical backlogs during the COVID-19 pandemic in Ontario, Canada. We sought to compare the socioeconomic status of patients who underwent cataract surgery in not-for-profit public hospitals with those who underwent this surgery in private for-profit surgical centres and to evaluate whether differences in access by socioeconomic status decreased after the infusion of public funding for private, for-profit centres.
Methods: We conducted a population-based study of all cataract operations in Ontario, Canada, between January 2017 and March 2022.
Lived experiences of transgender and nonbinary people in the perioperative context: a qualitative study.
CMAJ
July 2024
Department of Women's & Obstetric Anesthesia (MacCormick, Munro), IWK Health; Department of Anesthesia, Pain Management and Perioperative Medicine (MacCormick, Munro) and Centre for Learning and Teaching (Johnson), Dalhousie University; Centre for Research in Family Health (Burchell), IWK Health, Halifax, NS; Department of Anesthesiology and Pain Medicine (Lorello), University of Toronto; Department of Anesthesia and Pain Management (Lorello), University Health Network - Toronto Western Hospital; Department of Anesthesiology and Pain Medicine (George), University of Toronto, Toronto, Ont.; Department of Anesthesiology and Pain Medicine (Bould), Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ont.
Background: Transgender and nonbinary (TNB) people experience obstacles that create barriers to accessing health care, including stigmatization and health inequities. Our intention was to describe the lived experiences of TNB patients and identify potential gaps in the education of health care professionals.
Methods: We conducted a qualitative descriptive study influenced by phenomenology by interviewing with TNB adults who underwent surgery in Canada within the previous 5 years.
The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study.
CMAJ
May 2024
Faculty of Pharmaceutical Sciences (Zhang) and School of Population and Public Health (Anis), University of British Columbia; Centre for Advancing Health Outcomes (Zhang, Sun, Guh, Anis), Providence Research, Vancouver, BC; Leslie Dan Faculty of Pharmacy (Grootendorst), University of Toronto, Toronto, Ont.; Department of Economics (Hollis), University of Calgary, Calgary, Alta.
Background: The Patented Medicine Prices Review Board (PMPRB), the agency that regulates the prices of patented medicines in Canada, published proposed amendments to the regulatory framework in December 2017. Because of a series of changes and delays, the revised policy has not yet been finalized. We sought to evaluate the potential early impact of the uncertainty about the PMPRB policy on patented-medicine launches.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!